Notably, patients benefited from pembrolizumab regardless of whether they achieved a pathologic complete response (pCR), ...

Black women are more likely than white women to die from even the most treatable types of breast cancer, a study published ...

Hello Health Rounds Readers! Today we highlight research findings reported at ESMO 2024, the annual meeting of the European ...

Breast cancer runs in my family so I’ve always been vigilant about self-checking. As soon as I found a lump, in 2021, I went ...

In recent years, Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates ...

Black women are more likely than white women to die from even the most treatable types of breast cancer, new research finds.

For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant ...

Researchers have discovered new insights into tumor-induced B cell changes in blood and bone marrow of triple negative breast cancer patients. The findings show two distinct patterns of B cell ...

Opens in a new tab or window PD-1 inhibition before and after surgery for high-risk early triple-negative breast cancer (TNBC) led to significant improvement in overall survival (OS), according to ...

Professors Tom Powles and Peter Schmid recently delivered results from their phase three clinical trials during Sunday's ...